Mint-Tenofovir 300 mg (Tenofovir Disoproxil Fumarate TABLET) 300 MG

Mint-Tenofovir 300 mg tablets are an oral medication containing Tenofovir Disoproxil Fumarate, used for managing certain viral infections. This prescription drug is manufactured by Mint Pharmaceuticals Inc. in Canada.

Strength

300 MG

Manufacturer / TM Owner

MINT PHARMACEUTICALS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mint-Tenofovir 300 mg tablets are primarily used for the treatment of chronic hepatitis B and HIV-1 infection. Tenofovir Disoproxil Fumarate, the active ingredient, works by inhibiting the replication of the virus. This medication is often prescribed as part of a combination therapy to manage these conditions effectively.

Side Effects

Common effects of Mint-Tenofovir 300 mg tablets may include nausea, diarrhea, and headache. Some users might experience dizziness or fatigue. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Mint-Tenofovir 300 mg tablets should be handled with care. It is important to follow the prescription guidelines provided by your healthcare professional. Avoid taking this medication if you are allergic to Tenofovir Disoproxil Fumarate or any of its components. Always consult your healthcare provider before starting any new medication.

Avoid Interactions

Mint-Tenofovir 300 mg tablets may interact with other medications, including those that affect kidney function. It is important to inform your healthcare provider about all the medications you are currently taking. Alcohol and certain supplements may also interact with this medication, so it is advisable to discuss their use with your healthcare provider.

Frequently Asked Questions

Mint-Tenofovir 300 mg tablets are used for the treatment of chronic hepatitis B and HIV-1 infection.

Mint-Tenofovir 300 mg tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare professional.

Common side effects may include nausea, diarrhea, headache, dizziness, and fatigue.

It is advisable to consult your healthcare provider before consuming alcohol while taking Mint-Tenofovir 300 mg tablets.

Mint-Tenofovir 300 mg tablets should not be taken by individuals allergic to Tenofovir Disoproxil Fumarate. Always consult your healthcare provider before starting this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.